HLA AND RHEUMATIC DISEASES

HLA AND RHEUMATIC DISEASES

Bibliographic Details
Main Author:	Wordsworth, B
Format:	Journal article
Published:	1992

Similar Items

Immunogenetics and rheumatic diseases: 25 years on from HLA-B27
by: Wordsworth, P
Published: (1999)

SOME APPLICATIONS OF THE NEW GENETICS TO THE INVESTIGATION OF THE RHEUMATIC DISEASES
by: Wordsworth, B
Published: (1992)

'Full-house' rheumatic heart disease.
by: Mathew, S, et al.
Published: (2007)

Macrophage heterogeneity in the context of rheumatic diseases
by: Udalova, I, et al.
Published: (2016)

The validity of surrogate markers in rheumatic disease.
by: Emery, P, et al.
Published: (1993)

The prevalence and associated factors of clinical and subclinical rheumatic heart disease among rheumatic heart disease children admitted in HUSM
by: Zainol, Ahmad Rodzi
Published: (2015)

Mining the proteome associated with rheumatic and autoimmune diseases
by: Ruiz-Romero, C, et al.
Published: (2019)

Survival of Rheumatic Heart Disease in Indonesian Children
by: Arafuri, Nadya, et al.
Published: (2022)

Age-related mechanisms in the context of rheumatic disease
by: Alsaleh, G, et al.
Published: (2022)

T-cell receptors and rheumatic disease: approaches to repertoire analysis.
by: Bowness, P, et al.
Published: (1992)

Mobile phone-based rheumatic heart disease detection
by: Springer, D
Published: (2015)

Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease
by: Macleod, C, et al.
Published: (2019)

Screening for rheumatic diseases in the MS clinic: fulfilling the diagnostic criteria?
by: Rolinski, M, et al.
Published: (2009)

Complementary and alternative medicines (CAM) - Use in patients with rheumatic diseases.
by: Sandhu, S, et al.
Published: (2003)

The use of complementary and alternative medicines (CAM) in patients with rheumatic diseases
by: Famuboni, A, et al.
Published: (2003)

097 Are we using too much hydroxychloroquine in patients with rheumatic diseases?
by: Worth, C, et al.
Published: (2016)

Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases
by: Ntusi, N, et al.
Published: (2018)

The spectrum of inflammatory rheumatic disorders.
by: Walker-Bone, K, et al.
Published: (2000)

The validation of a new epidemiological model for rheumatic heart disease: from asymptomatic to symptomatic disease
by: Mirabel, M, et al.
Published: (2016)

Antinuclear antibodies in non-systemic autoimmune rheumatic disease dermatological conditions
by: Mahayidin, Hasni, et al.
Published: (2021)

Use of a computerised system to facilitate management of autoimmune rheumatic diseases
by: Luqmani, R, et al.
Published: (2017)

Development of a paediatric anxiety questionnaire (PAQ) in children with rheumatic diseases
by: Malone, P, et al.
Published: (2001)

PCR-SSO typing in HLA-disease association studies.
by: Wordsworth, P
Published: (1991)

Topical agents in the treatment of rheumatic pain.
by: Moore, R, et al.
Published: (2008)

INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE
by: Moots, R, et al.
Published: (1993)

Screening for rheumatic diseases in the MS clinic: fulfilling the McDonald diagnostic criteria?
by: Rolinski, M, et al.
Published: (2009)

INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE
by: Moots, R, et al.
Published: (1993)

The human leukocyte antigen locus and rheumatic heart disease susceptibility in South Asians and Europeans
by: Auckland, K, et al.
Published: (2020)

Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)’s recommendations for cardiovascular risk management?
by: Conrad, N, et al.
Published: (2022)

HLA AND DISEASE
by: Bodmer, W
Published: (1979)

A locus telomeric to HLA-DPB encodes susceptibility to coeliac disease.
by: Rosenberg, WM, et al.
Published: (1989)

Temporal Trends In The Prescribing Of Disease Modifying Anti-Rheumatic Drugs For Rheumatoid Arthritis and The Impact Of Guidelines.
by: Wallace, G, et al.
Published: (2013)

Translating GWAS in rheumatic disease: approaches to establishing mechanism and function for genetic associations with ankylosing spondylitis
by: Osgood, J, et al.
Published: (2018)

Clinical outcomes for young people with screening-detected and clinically-diagnosed rheumatic heart disease in Fiji
by: Engelman, D, et al.
Published: (2017)

Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji
by: Engelman, D, et al.
Published: (2016)

Nimesulide improves the disease modifying anti-rheumatic profile of methotrexate in mice with collagen-induced arthritis.
by: Al-Abd, A, et al.
Published: (2010)

The Diagnostic Role of Skin Manifestations in Rheumatic Diseases in Children: A Critical Review of Paediatric Vasculitis
by: Di Ludovico, A, et al.
Published: (2024)

Outcomes for patients with rheumatic heart disease after cardiac surgery followed at rural district hospitals in Rwanda
by: Rusingiza, EK, et al.
Published: (2018)

The changing use of disease-modifying anti-rheumatic drugs in individuals with RA from The General Practice Research Database (GPRD) the changing use of disease-modifying anti-rheumatic drugs for RA from The General Practice Research Database
by: Edwards, C, et al.
Published: (2005)

Intensive care unit (ICU) outcomes in patients with rheumatic diseases: A retrospective multicenter, international observational study
by: Dellaripa, P, et al.
Published: (2001)